Revenio Group Oyj (0KFH.L)
EUR 26.78
(1.9%)
EUR 26.78
(1.9%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 96.57 Million EUR | -0.39% |
| 2022 | 96.97 Million EUR | 23.1% |
| 2021 | 78.77 Million EUR | 29.0% |
| 2020 | 61.06 Million EUR | 23.43% |
| 2019 | 49.47 Million EUR | 61.37% |
| 2018 | 30.65 Million EUR | 14.43% |
| 2017 | 26.79 Million EUR | 14.33% |
| 2016 | 23.43 Million EUR | 15.72% |
| 2015 | 20.25 Million EUR | 26.32% |
| 2014 | 16.03 Million EUR | -37.69% |
| 2013 | 25.72 Million EUR | 1.36% |
| 2012 | 25.38 Million EUR | -23.73% |
| 2011 | 33.28 Million EUR | 13.07% |
| 2010 | 29.43 Million EUR | -1.81% |
| 2009 | 29.97 Million EUR | -33.6% |
| 2008 | 45.14 Million EUR | 0.0% |
| 2005 | 11.45 Million EUR | -37.89% |
| 2004 | 18.44 Million EUR | -18.36% |
| 2003 | 22.59 Million EUR | -29.41% |
| 2002 | 32 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 23.6 Million EUR | -18.9% |
| 2024 Q3 | 23.9 Million EUR | -5.91% |
| 2024 Q2 | 25.4 Million EUR | 7.63% |
| 2023 Q2 | 22.3 Million EUR | -3.88% |
| 2023 Q1 | 23.2 Million EUR | -17.95% |
| 2023 FY | 96.6 Million EUR | -0.39% |
| 2023 Q4 | 29.1 Million EUR | 32.27% |
| 2023 Q3 | 22 Million EUR | -1.35% |
| 2022 Q1 | 20.2 Million EUR | -15.05% |
| 2022 FY | 96.97 Million EUR | 23.1% |
| 2022 Q4 | 28.27 Million EUR | 17.33% |
| 2022 Q3 | 24.1 Million EUR | -1.23% |
| 2022 Q2 | 24.4 Million EUR | 20.79% |
| 2021 Q1 | 16.8 Million EUR | -14.58% |
| 2021 FY | 78.77 Million EUR | 29.0% |
| 2021 Q4 | 23.77 Million EUR | 22.57% |
| 2021 Q3 | 19.4 Million EUR | 2.65% |
| 2021 Q2 | 18.9 Million EUR | 12.5% |
| 2020 FY | 61.06 Million EUR | 23.43% |
| 2020 Q2 | 13.7 Million EUR | 15.13% |
| 2020 Q3 | 15.8 Million EUR | 15.33% |
| 2020 Q1 | 11.9 Million EUR | -20.53% |
| 2020 Q4 | 19.66 Million EUR | 24.47% |
| 2019 FY | 49.47 Million EUR | 61.37% |
| 2019 Q1 | 8.4 Million EUR | -2.98% |
| 2019 Q4 | 14.97 Million EUR | 4.71% |
| 2019 Q3 | 14.3 Million EUR | 21.19% |
| 2019 Q2 | 11.8 Million EUR | 40.48% |
| 2018 Q1 | 7 Million EUR | -7.79% |
| 2018 Q4 | 8.65 Million EUR | 17.0% |
| 2018 FY | 30.65 Million EUR | 14.43% |
| 2018 Q2 | 7.6 Million EUR | 8.57% |
| 2018 Q3 | 7.4 Million EUR | -2.63% |
| 2017 Q1 | 6 Million EUR | -9.56% |
| 2017 FY | 26.79 Million EUR | 14.33% |
| 2017 Q3 | 6.4 Million EUR | -4.48% |
| 2017 Q4 | 7.59 Million EUR | 18.61% |
| 2017 Q2 | 6.7 Million EUR | 11.67% |
| 2016 FY | 23.43 Million EUR | 15.72% |
| 2016 Q4 | 6.63 Million EUR | 14.38% |
| 2016 Q2 | 5.8 Million EUR | 11.54% |
| 2016 Q3 | 5.8 Million EUR | 0.0% |
| 2016 Q1 | 5.2 Million EUR | -4.59% |
| 2015 Q1 | 4.6 Million EUR | 629.0% |
| 2015 FY | 20.25 Million EUR | 26.32% |
| 2015 Q4 | 5.45 Million EUR | 2.83% |
| 2015 Q3 | 5.3 Million EUR | 8.16% |
| 2015 Q2 | 4.9 Million EUR | 6.52% |
| 2014 Q2 | 6.8 Million EUR | 7.94% |
| 2014 Q1 | 6.3 Million EUR | 25.32% |
| 2014 FY | 16.03 Million EUR | -37.69% |
| 2014 Q4 | 631 Thousand EUR | -87.38% |
| 2014 Q3 | 5 Million EUR | -26.47% |
| 2013 Q4 | 5.02 Million EUR | -24.97% |
| 2013 Q3 | 6.7 Million EUR | -2.9% |
| 2013 Q1 | 7.1 Million EUR | 48.47% |
| 2013 Q2 | 6.9 Million EUR | -2.82% |
| 2013 FY | 25.72 Million EUR | 1.36% |
| 2012 FY | 25.38 Million EUR | -23.73% |
| 2012 Q1 | 7.7 Million EUR | -12.31% |
| 2012 Q3 | 6.6 Million EUR | 4.76% |
| 2012 Q2 | 6.3 Million EUR | -18.18% |
| 2012 Q4 | 4.78 Million EUR | -27.55% |
| 2011 Q3 | 8.2 Million EUR | -3.53% |
| 2011 Q4 | 8.78 Million EUR | 7.09% |
| 2011 FY | 33.28 Million EUR | 13.07% |
| 2011 Q1 | 8.8 Million EUR | -10.51% |
| 2011 Q2 | 8.5 Million EUR | -3.41% |
| 2010 Q3 | 6.5 Million EUR | 1.56% |
| 2010 Q1 | 6.6 Million EUR | -5.4% |
| 2010 FY | 29.43 Million EUR | -1.81% |
| 2010 Q2 | 6.4 Million EUR | -3.03% |
| 2010 Q4 | 9.83 Million EUR | 51.29% |
| 2009 Q1 | 9.1 Million EUR | 0.0% |
| 2009 Q4 | 6.97 Million EUR | 2.6% |
| 2009 FY | 29.97 Million EUR | -33.6% |
| 2009 Q3 | 6.8 Million EUR | -4.23% |
| 2009 Q2 | 7.1 Million EUR | -21.98% |
| 2008 FY | 45.14 Million EUR | 0.0% |
| 2005 FY | 11.45 Million EUR | -37.89% |
| 2004 FY | 18.44 Million EUR | -18.36% |
| 2003 FY | 22.59 Million EUR | -29.41% |
| 2002 FY | 32 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Cegedim SA | 615.99 Million EUR | 84.322% |
| Guerbet SA | 795.65 Million EUR | 87.862% |
| Nexus AG | 241.45 Million EUR | 60.003% |
| Bastide Le Confort Médical SA | 529.75 Million EUR | 81.77% |
| Drägerwerk AG & Co. KGaA | 3.37 Billion EUR | 97.137% |
| Sartorius Aktiengesellschaft | 3.39 Billion EUR | 97.156% |
| LNA Santé SA | 736.08 Million EUR | 86.88% |
| Siemens Healthineers AG | 22.36 Billion EUR | 99.568% |
| Medios AG | 1.78 Billion EUR | 94.589% |
| Equasens Société anonyme | 219.78 Million EUR | 56.059% |
| Stratec SE | 261.91 Million EUR | 63.126% |